Ibalgin Rapidcaps (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are required for the production of prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, lowers body temperature, and reduces the transmission of pain signals.

The appropriate dose of Ibalgin Rapidcaps is determined by a qualified prescriber based on the patient’s age, weight, clinical condition and response to therapy. Healthcare professionals follow local guidelines to select the strength and frequency that best manage the individual’s symptoms.

Ibuprofen should be used with caution during pregnancy, especially in the third trimester, because it may affect fetal circulation and prolong labor. It is also excreted in breast milk; therefore, breastfeeding mothers should consult their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibalgin Rapidcaps delivers ibuprofen, which has a relatively rapid onset of action and a well‑characterised safety profile compared with some other NSAIDs. While efficacy for pain and fever is comparable across the class, individual tolerability, dosing frequency and specific drug‑interaction profiles may differ.

Store Ibalgin Rapidcaps at room temperature, below 25 °C. Keep the capsules in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Ibalgin Rapidcaps is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce the likelihood of gastrointestinal discomfort. Follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe allergic reactions such as anaphylaxis, and rare but serious skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, sudden kidney problems, or severe skin changes.

Individuals with known hypersensitivity to ibuprofen or any other NSAID, those with active gastrointestinal ulceration, severe renal or hepatic impairment, and patients who have experienced a recent cardiovascular event should avoid using Ibalgin Rapidcaps unless directed otherwise by a healthcare professional.